The case that HHV-6, HHV-7, and HH8 should not be called herpes viruses and should be in a category all by themselves.

 From Perplexity A.I.

Make the case that HHV-6, HHV-7, and HH8 should not be called herpes viruses and should be in a category all by themselves.


There is a compelling case for classifying HHV-6, HHV-7, and HHV-8 in a distinct category separate from traditional herpesviruses, based on several unique biological, genomic, and functional properties that set them apart from the rest of the Herpesviridae family.

Major Differences from Classic Herpesviruses
Cell Entry and Receptors: HHV-6A, HHV-6B, and HHV-7 use different cellular receptors than classic alpha herpesviruses (HSV-1, HSV-2, VZV). For example, HHV-6A targets CD46 (on all nucleated cells), HHV-6B uses CD134, and HHV-7 uses CD4. This is unlike HSVs, which have a more limited tropism, and contributes to broad tissue targeting by HHV-6/7.

Unique Integration and Latency: Unlike other human herpesviruses, HHV-6A and HHV-6B can integrate into human chromosomal telomeres, allowing for both vertical (transgenerational) transmission and persistent latent infection in unique ways. This chromosomal integration is unreported for other herpesviruses, making it a taxonomic anomaly.

Distinct Genomic Features: These viruses, especially HHV-8, possess numerous host-derived genes—a process called molecular piracy—enabling them to manipulate cell growth, evade immunity, and even induce oncogenesis. The extent and diversity of these pirated genes far exceeds what is observed in classic herpesviruses.

Epidemiology and Disease Association
Prevalence and Disease Manifestation: HHV-6 and HHV-7 are nearly universal in the global population, but their primary disease associations differ from most herpesviruses, causing roseola and other childhood exanthems. HHV-8, meanwhile, is closely linked to Kaposi’s sarcoma and has a distinct demographic and geographic distribution compared to the other HHVs.

Oncogenic Potential: The strong oncogenicity of HHV-8 (Kaposi's sarcoma, primary effusion lymphoma) and the suspected oncogenic capacity of HHV-6 and 7, via telomeric integration and gene piracy, place them closer to gammaherpesviruses like EBV, but distinct in their tissue tropism and host interactions.

Taxonomic Arguments
Roseolovirus Genus: HHV-6 and HHV-7 are classified in the Roseolovirus genus, which is already a distinction from other betaherpesviruses like CMV. But their biological behavior suggests an even broader re-classification is justified.

ICTV Reclassification: Recent taxonomic developments already split HHV-6A and HHV-6B as separate species, not just variants. This acknowledges their profound biological and epidemiological differences and hints at the fluidity needed in classifying these viruses.

Conceptual and Practical Justification
Biological Uniqueness: The combination of unique integration mechanisms, cellular targeting, gene acquisition, and disease association means that HHV-6, HHV-7, and HHV-8 constitute a distinct evolutionary and functional group within (or even beside) the current Herpesviridae family.

Clinical Implications: Distinct diagnostic and therapeutic challenges posed by these viruses—such as their resistance to standard anti-herpes therapies, and the complexity of detecting latent or chromosomally integrated forms—support a rethinking of classification to better guide research and treatment.

Summary Table: Key Distinctions
Feature Classic Herpesviruses (HSV, VZV, CMV) HHV-6, HHV-7, HHV-8
Main receptors Various, generally limited CD46, CD134, CD4—broad tropism 
Integration into host DNA Episomal latency only Telomeric chromosomal integration (HHV-6A/B) 
Disease spectrum Encephalitis, genital/oral lesions, etc Roseola, pityriasis rosea, Kaposi’s sarcoma 
Oncogenic genes Few Extensive host gene piracy, strong oncogenicity 
Response to antivirals Standard regimens effective Poor response, alternative therapies needed 
In conclusion, based on their fundamental biological, genomic, and clinical differences, HHV-6, HHV-7, and HHV-8 should arguably be reclassified outside the core herpesvirus category, either within an expanded or entirely new viral family.

Popular Posts in the Last 7 Days

Dr. Bhupesh Prusty and Professor Thomas Rudel discuss their HHV-6 research

Is Chronic Fatigue Syndrome the other AIDS epidemic in the gay community?

Inconsistencies in the HIV theory of AIDS

Why HIV should be referred to as "a red herring."

Oral Kaposi's Sarcoma looks like the Crimson Crescents in Chronic Fatigue Syndrome patients.

The case that HHV-6 maybe the biggest unrecognized public health threat in the world.

Popular Post in the Last 30 Days

Why HIV should be referred to as "a red herring."

The case that HHV-6 maybe the biggest unrecognized public health threat in the world.

Dr. Rebecca Culshaw Smith's book is discussed on Twitter

Inconsistencies in the HIV theory of AIDS

Dr. Bhupesh Prusty and Professor Thomas Rudel discuss their HHV-6 research

Ablashi discusses HHV-6, AIDS, Alzheimer's, and Chronic Fatigue Syndrome

Popular Posts from the Last Year

Oral Kaposi's Sarcoma looks like the Crimson Crescents in Chronic Fatigue Syndrome patients.

Dr. Rebecca Culshaw Smith's book is discussed on Twitter

Ablashi discusses HHV-6, AIDS, Alzheimer's, and Chronic Fatigue Syndrome

Dr. Bhupesh Prusty and Professor Thomas Rudel discuss their HHV-6 research

Why HIV should be referred to as "a red herring."

Doctors discuss using Chloroquine for COVID-19

All Time Most Popular Posts

Dr. Bhupesh Prusty and Professor Thomas Rudel discuss their HHV-6 research

Anthony Fauci was part of the gang that silenced and destroyed Judy Mikovits.

Was Judy Mikovits destroyed because her XMRV work would have ultimately shown HIV is a total fraud?

Is Chronic Fatigue Syndrome the other AIDS epidemic in the gay community?